HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allison Pike Selected Research

Cytarabine (Cytosar-U)

9/2019Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allison Pike Research Topics

Disease

1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2019
1Neoplasms (Cancer)
09/2019

Drug/Important Bio-Agent (IBA)

1NivolumabIBA
09/2019
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2019
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
09/2019

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2019
1Therapeutics
09/2019
1Stem Cell Transplantation
09/2019
1Induction Chemotherapy
09/2019